MediPharm Labs Enters New GMP Manufacturing Deal with Sunco Green Pharmaceutical Pty Ltd. in Australia

MediPharm Labs Corp announced its wholly owned subsidiary, MediPharm Labs Australia Pty Ltd has entered into a new white-label supply agreement with Sunco Green Pharmaceutical Pty Ltd. 

This marks MediPharm Labs’ 12th supply agreement to bring GMP certified finished products to a burgeoning Australian medical cannabis market and in an emerging New Zealand market. The Therapeutic Goods Administration (“TGA”) reported a record number of patient approvals in September 2020. A total of 6,206 patients were approved for medical cannabis treatment, a 72% increase over approvals reported in October 2019(1)(2). Since the start of the Australian special access program, 67,000 applications have been approved.

Pat McCutcheon, CEO, MediPharm Labs Said: “With our TGA GMP-certified manufacturing capabilities, distribution channels, track-record of execution and supply cannabis of API we continue to be the go-to provider for new pharmaceutical and health and wellness companies entering the burgeoning cannabis market especially in Australia, We are excited to add Sunco Green Pharmaceuticals to our platform as we work together to bring high quality and innovative medical cannabis products to a growing patient consumer base in Australia.”

Under the two-year agreement, subject to further renewals, MediPharm Labs Australia will supply a full range of specially formulated CBD and THC cannabis oil products that will be sold under the Sunco Green Label. Products are expected to launch in Q4 2020.

Shaun Anderson, CEO and Managing Director of Sunco Green Said: “There has been a growing awareness of the clinical benefits of the different forms of Medicinal Cannabis for some years, and with legislation opening the door for patient access in 2016, there has been an ever- increasing demand, Our agreement with MediPharm Labs, a world class GMP certified Medicinal Cannabis Manufacturer, is our first step in the journey for a locally based and owned business to meet this demand.”

“Sunco Green sees the development of strong industry relationships as crucial to achieving our mission, and also for the overall development and health of the Medicinal Cannabis Industry. Our agreement with MediPharm Labs is our first key partnership, and we look ahead to a long and mutually beneficial business association.”

About Sunco Green Pharmaceutical Pty Ltd, a new entrant to the Australian Medicinal Cannabis Industry

Sunco Green was established in early 2020 to address a need and growing demand for patient access to the clinical benefits of medical cannabis. Its founding members bring deep experience from long tenures in Pharmacy, Medical Device and Entrepreneurship. Sunco Green is committed to building a sustainable business that will be part of the local Australian cannabis community and the wider cannabis industry for the next decade and beyond.

Related Posts

Subscribe Our Newsletter